Skip to content

Evaluation of the effect of topical thermotherapy ( with thermomed) in the treatment of anthroponotic Leishmaniasis in a pilot study

Evaluation of the effect of topical thermotherapy ( with thermomed) in the treatment of anthroponotic Leishmaniasis in a pilot study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015011816554N2
Enrollment
20
Registered
2016-01-03
Start date
2015-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anthroponotic Leishmaniasis. Cutaneous leishmaniasis

Interventions

Thermotherapy: one time (30 seconds at 50 ° C).
Treatment - Other
Thermotherapy: one time (30 seconds at 50 ° C)

Sponsors

Vice chancellor for research of Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: inclusion criteria: clinical features of lesion consistent with Anthroponrtic leishmaniasis; specified L. tropica with Molecular method PCR; the patient has indication for local therapy based on clinical judgment; up to 6 months of the lesion duration; the patient already not had any treatment for cutaneous Leishmaniasis; consent for participate in this study. Exclusion Criteria: incompetence for regular follow-up; presence of secondary infection of the lesions based on clinical features and physician judgment; Use of other treatments during the study; Very extensive lesions (more than ten centimeters); presence of necrosis and the lesions deeper than hypodermis; Lesions on the face and joints; having a pacemaker and prosthetic; pregnancies.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Lesion healing. Timepoint: Three monthly. Method of measurement: Measuring the size of induration and formidability.

Secondary

MeasureTime frame
Side effects. Timepoint: Three monthly. Method of measurement: Efficacy and side effects including local and systemic reactions will be recorded according to patient's report and clinician observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Vahid Mashayekhi-Ghoyonlo

Mashhad University of Medical Sciences

mashayekhiv@mums.ac.ir, src@mums.ac.ir+98 51 3802 2490

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026